IONS•benzinga•
JP Morgan Maintains Neutral on Ionis Pharmaceuticals, Raises Price Target to $48
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on June 12, 2025 by benzinga